Drug-drug interactions that matter.
It is increasingly difficult to keep track of information on drug-drug interactions in HIV therapeutics, and the clinical implications of much of the data reported are not immediately evident. Nevertheless, knowledge of drug-drug interactions is necessary to preserve antiretroviral efficacy and to avoid undue risk of toxicity. The following article reviews important drug-drug interactions and accumulating data on newer antiretroviral agents.
Back
David J
DJ
The University of Liverpool, Liverpool, UK.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000494:pharmacology*; D004347:Drug Interactions; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000494:pharmacology; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors